My learning expectations were to research and learn about various clinical trials for glioblastomas, breast cancer, and lung cancers and to gain insight into the market landscape for drug development. I built a project that can be used as a reference for hundreds of different clinical trials containing drug names, primary competitions, mechanisms, routes of administration, and company data. I primarily conducted my detailed research within clinicaltrials.gov but utilized many other scientific sources as well. I have been working on my project since September.  In December, I had the opportunity to present my project results to the management team at Reglagene.  

As an intern at Reglagene, I learned the components of a clinical trial and the time, resources, and marketing that are put into it. I saw that clinical trials mostly have three objectives: creating new drugs, repurposing old drugs, or trying to improve a current treatment method. I noticed that new drugs are commonly small-molecule drugs or biologics and also learned many objectives of big pharmaceutical companies to incorporate into my project. These specific data points helped create a more cohesive image of the market landscape, as well as strengthened my understanding of the mechanisms of small molecule drugs and biologics from the foundation of my major-specific courses from school.